Effectiveness and safety study of tezepelumab in adults & adolescent participants with severe asthma in the United States

Trial Identifier: D5180C00032
Sponsor: AstraZeneca
NCTID:: NCT05329194
Start Date: April 2022
Primary Completion Date: July 2025
Study Completion Date: July 2025
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
US, AL Hoover, AL, US, 35244
US, AL Mobile, AL, US, 36608
US, AZ Gilbert, AZ, US, 85234
US, CA La Jolla, CA, US, 92093
US, CA Westminster, CA, US, 92683
US, CA Whittier, CA, US, 90603
US, CO Colorado Springs, CO, US, 80907
US, CT New Haven, CT, US, 06510
US, DC Washington, DC, US, 20037
US, IL Chicago, IL, US, 60611
US, KY Lexington, KY, US, 40509
US, LA New Orleans, LA, US, 70112
US, MD Upper Marlboro, MD, US, 20772
US, MD White Marsh, MD, US, 21162
US, MI Ann Arbor, MI, US, 48109
US, MI Ypsilanti, MI, US, 48197
US, MN Saint Paul, MN, US, 55109
US, MO Saint Louis, MO, US, 63110
US, NC Chapel Hill, NC, US, 27514
US, NC Durham, NC, US, 27709
US, NE Lincoln, NE, US, 68505
US, NE Omaha, NE, US, 68114
US, New York Hollis, New York, US, 11423
US, NY Bronx, NY, US, 10465
US, NY Horseheads, NY, US, 14845
US, NY Rochester, NY, US, 14642
US, NY Valhalla, NY, US, 10595
US, OH Cincinnati, OH, US, 45229
US, OH Toledo, OH, US, 43617
US, OK Oklahoma City, OK, US, 73120
US, PA Altoona, PA, US, 16602
US, PA Philadelphia, PA, US, 19140
US, RI Warwick, RI, US, 02886
US, SC Greenville, SC, US, 29607
US, TX Dallas, TX, US, 75246
US, TX Fort Worth, TX, US, 76107
US, TX Mckinney, TX, US, 75069
US, TX San Antonio, TX, US, 78229
US, VA Charlottesville, VA, US, 22903
US, WA Vancouver, WA, US, 98664
US, WI Madison, WI, US, 53792